Free Trial
→ URGENT: Someone's Moving Gold Out of London... (From Golden Portfolio) (Ad) Buy HCM Stock  Free HCM Stock Alerts

HUTCHMED (HCM) Financials

HUTCHMED logo
$15.00 +0.20 (+1.35%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$14.99 -0.01 (-0.07%)
As of 05/2/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for HUTCHMED

Annual Income Statements for HUTCHMED

This table shows HUTCHMED's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -33 -35 12 -27 -75 -106 -126 -195 -361 101 38
Consolidated Net Income / (Loss)		 -4.09 10 15 -23 -71 -104 -116 -167 -360 101 38
Net Income / (Loss) Continuing Operations		 -6.12 10 15 -23 -71 -104 -116 -167 -360 101 38
Total Pre-Tax Income 		-20 -11 -47 -54 -87 -141 -190 -216 -410 58 -1.11
Total Operating Income		 -18 -9.77 -47 -53 -93 -146 -197 -328 -408 18 -44
Total Gross Profit		 34 73 60 65 70 45 39 98 115 454 281
Total Revenue		 87 178 216 241 214 205 228 356 426 838 630
Operating Revenue		 87 178 216 241 214 - - 356 426 838 630
Total Cost of Revenue		 53 105 156 176 144 160 189 258 311 384 349
Operating Cost of Revenue		 53 105 156 176 144 160 189 258 311 384 349
Total Operating Expenses		 52 83 106 119 163 191 236 426 523 435 325
Selling, General & Admin Expense		 17 30 40 43 49 53 61 127 136 133 113
Research & Development Expense		 30 47 67 76 114 138 175 299 387 302 212
Total Other Income / (Expense), net		 -1.70 -0.77 -0.66 -0.12 5.99 5.28 6.93 113 -2.73 40 43
Interest Expense		 1.52 1.40 1.63 1.46 1.01 1.03 0.79 0.59 0.65 0.76 2.87
Interest & Investment Income		 0.56 0.45 0.50 1.22 5.98 4.94 3.24 123 9.60 36 40
Other Income / (Expense), net		 -0.74 0.18 0.47 0.12 1.02 1.37 4.49 -10 -12 4.55 5.39
Income Tax Expense		 1.34 1.61 4.33 3.08 3.96 3.27 4.83 12 -0.28 4.51 7.19
Other Gains / (Losses), net		 15 23 66 34 19 41 79 61 50 47 46
Net Income / (Loss) Attributable to Noncontrolling Interest		 29 45 2.86 3.77 3.52 2.35 10 28 0.45 0.31 0.44
Basic Earnings per Share		 - ($0.64) $0.20 ($0.04) ($0.11) ($0.16) ($0.18) ($0.25) ($0.43) $0.12 $0.04
Weighted Average Basic Shares Outstanding		 52.56M 54.66M 59.72M 617.17M 664.26M 665.68M 697.93M 792.68M 847.14M 849.65M 855.35M
Diluted Earnings per Share		 - ($0.64) $0.20 ($0.04) ($0.11) ($0.16) ($0.18) ($0.25) ($0.43) $0.12 $0.04
Weighted Average Diluted Shares Outstanding		 52.56M 54.66M 59.97M 617.17M 664.26M 665.68M 697.93M 792.68M 847.14M 869.20M 872.83M
Weighted Average Basic & Diluted Shares Outstanding		 - - 60.71M 617.17M 664.26M 665.68M 697.93M 864.53M 864.78M 871.26M 871.60M

Quarterly Income Statements for HUTCHMED

No quarterly income statements for HUTCHMED are available.

Annual Cash Flow Statements for HUTCHMED

This table details how cash moves in and out of HUTCHMED's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -7.92 -7.01 57 15 34 116 177 346 204 -249 -130
Net Cash From Operating Activities		 8.36 -9.39 -9.57 -8.94 -33 -81 -62 -204 -269 219 0.50
Net Cash From Continuing Operating Activities		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Income / (Loss) Continuing Operations		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Investing Activities		 -15 8.86 -34 -261 44 119 -125 -306 297 -291 -96
Net Cash From Continuing Investing Activities		 -15 8.86 -34 -261 44 119 -125 -306 297 -291 -96
Purchase of Property, Plant & Equipment		 -3.73 -3.32 -4.33 -5.02 -6.36 -8.57 -7.95 -16 -37 -33 -18
Acquisitions		 0.00 0.00 -5.00 -7.00 -8.00 8.69 - 0.00 0.00 -8.09 0.00
Purchase of Investments		 - 0.00 -81 -325 -904 -478 -733 -1,356 -1,202 -1,628 -1,849
Divestitures		 0.69 - - 0.00 - 0.00 - 0.00 0.00 5.10 0.00
Sale and/or Maturity of Investments		 8.86 12 57 76 962 597 629 921 1,518 1,343 1,769
Other Investing Activities, net		 -21 - - - 0.00 0.00 -14 145 17 29 1.28
Net Cash From Financing Activities		 -0.64 -5.47 92 273 -8.23 -1.49 296 650 -83 49 -31
Net Cash From Continuing Financing Activities		 -0.64 -5.47 92 273 -8.23 -1.49 296 650 -83 49 -31
Repayment of Debt		 -14 -6.41 -29 -49 -32 -27 0.00 -0.58 -27 0.00 -31
Repurchase of Common Equity		 0.00 -3.11 -14 -9.94 -6.19 -0.35 -21 -57 -48 -9.07 -36
Payment of Dividends		 -1.18 -0.59 -0.56 -1.59 -1.28 -1.28 -1.46 -9.89 -26 -9.07 -1.00
Issuance of Debt		 8.21 3.21 25 33 27 27 0.00 0.00 18 62 36
Issuance of Common Equity		 5.74 1.37 111 302 3.87 0.25 319 717 0.17 5.09 0.79
Effect of Exchange Rate Changes		 -0.42 -7.01 -1.78 2.36 -1.90 -1.50 5.55 2.43 -9.49 -6.47 -3.40
Cash Interest Paid		 1.47 1.22 1.57 0.76 0.98 0.92 0.82 0.43 0.15 0.42 2.51
Cash Income Taxes Paid		 -0.91 0.51 2.66 3.84 3.75 3.25 5.94 5.01 19 3.73 3.59

Quarterly Cash Flow Statements for HUTCHMED

No quarterly cash flow statements for HUTCHMED are available.

Annual Balance Sheets for HUTCHMED

This table presents HUTCHMED's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 230 342 598 532 465 724 1,373 1,029 1,280 1,274
Total Current Assets		 90 167 432 371 317 531 1,212 840 1,097 1,067
Cash & Equivalents		 32 79 85 86 121 236 378 313 284 154
Short-Term Investments		 0.00 24 273 215 96 200 634 318 603 682
Note & Lease Receivable		 - - - - - - - 0.00 0.00 0.00
Accounts Receivable		 48 46 51 44 68 48 84 99 145 163
Inventories, net		 9.56 13 12 12 16 20 36 57 50 50
Other Current Assets		 - 4.31 11 13 16 28 81 53 15 17
Plant, Property, & Equipment, net		 8.51 9.95 14 17 21 24 41 76 100 92
Total Noncurrent Assets		 132 165 152 145 127 169 119 114 83 115
Long-Term Investments		 120 159 144 138 99 140 76 74 48 83
Noncurrent Deferred & Refundable Income Taxes		 - 0.00 0.63 0.58 0.82 1.52 9.40 15 15 12
Other Noncurrent Operating Assets		 6.58 1.77 1.65 1.36 11 28 33 24 19 20
Total Liabilities & Shareholders' Equity		 230 342 598 532 465 724 1,373 1,029 1,280 1,274
Total Liabilities		 127 138 113 120 152 205 333 393 536 502
Total Current Liabilities		 81 95 105 85 113 158 312 354 403 377
Short-Term Debt		 23 20 30 - - 0.00 27 0.00 31 23
Accounts Payable		 57 41 31 26 24 32 41 71 36 43
Current Deferred Revenue		 1.17 0.96 1.30 2.54 2.11 - - 13 58 50
Current Deferred & Payable Income Tax Liabilities		 0.31 1.64 0.98 0.56 1.83 1.12 16 1.11 2.58 1.55
Other Current Liabilities		 - 32 41 56 85 126 228 268 275 259
Total Noncurrent Liabilities		 46 43 8.37 34 39 47 21 39 133 126
Long-Term Debt		 27 27 0.00 27 27 27 0.00 18 48 59
Noncurrent Deferred Revenue		 5.63 4.30 2.80 0.41 0.13 - - 0.19 69 48
Noncurrent Deferred & Payable Income Tax Liabilities		 3.42 4.00 4.45 4.84 3.16 5.06 2.77 2.71 1.48 2.99
Other Noncurrent Operating Liabilities		 10 8.13 1.12 2.40 9.01 15 19 18 14 15
Commitments & Contingencies		 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 102 204 485 412 313 519 1,040 637 743 772
Total Preferred & Common Equity		 83 184 462 389 288 484 987 610 731 760
Total Common Equity		 83 184 462 389 288 484 987 610 731 760
Common Stock		 170 269 563 572 582 895 1,592 1,584 1,610 1,605
Retained Earnings		 -92 -80 -107 -183 -290 -416 -610 -971 -871 -833
Accumulated Other Comprehensive Income / (Loss)		 5.02 -4.28 5.43 -0.24 -3.85 4.48 5.57 -1.90 -8.16 -12
Noncontrolling Interest		 19 20 23 23 25 35 53 27 13 12

Quarterly Balance Sheets for HUTCHMED

No quarterly balance sheets for HUTCHMED are available.

Annual Metrics and Ratios for HUTCHMED

This table displays calculated financial ratios and metrics derived from HUTCHMED's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 104.06% 21.26% 11.63% -11.23% -4.31% 11.27% 56.21% 19.73% 96.52% -24.80%
EBITDA Growth		 0.00% 49.54% -382.18% -15.30% -71.90% -58.28% -32.52% -76.15% -23.88% 105.47% -267.15%
EBIT Growth		 0.00% 49.54% -382.18% -15.30% -71.90% -58.28% -32.52% -76.15% -23.88% 105.47% -267.15%
NOPAT Growth		 0.00% 46.49% -377.91% -14.39% -73.43% -58.01% -34.35% -66.94% -24.18% 105.94% -280.45%
Net Income Growth		 0.00% 355.19% 39.61% -257.75% -210.44% -45.44% -11.42% -44.60% -115.75% 128.05% -62.24%
EPS Growth		 0.00% 0.00% 131.25% -120.00% -175.00% -45.45% -12.50% -38.89% -72.00% 127.91% -66.67%
Operating Cash Flow Growth		 0.00% -212.27% -1.96% 6.54% -267.29% -146.33% 23.29% -229.04% -31.52% 181.63% -99.77%
Free Cash Flow Firm Growth		 0.00% 0.00% -187.73% -192.65% 14.74% -142.27% 32.58% -178.13% -8.62% 130.76% -199.02%
Invested Capital Growth		 0.00% 0.00% -2,772.94% 209.33% -102.21% 8,685.09% -222.29% 24.63% -128.86% -124.94% 42.67%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 38.76% 41.16% 27.65% 27.11% 32.77% 21.84% 17.31% 27.49% 27.04% 54.12% 44.64%
EBITDA Margin		 -21.76% -5.38% -21.39% -22.10% -42.79% -70.78% -84.30% -95.06% -98.35% 2.74% -6.08%
Operating Margin		 -20.91% -5.48% -21.61% -22.15% -43.27% -71.45% -86.27% -92.19% -95.61% 2.19% -6.94%
EBIT Margin		 -21.76% -5.38% -21.39% -22.10% -42.79% -70.78% -84.30% -95.06% -98.35% 2.74% -6.08%
Profit (Net Income) Margin		 -4.68% 5.85% 6.74% -9.52% -33.29% -50.60% -50.67% -46.90% -84.52% 12.06% 6.06%
Tax Burden Percent		 20.47% -98.93% -30.74% 42.89% 82.26% 73.48% 60.88% 77.43% 87.81% 173.38% -3,448.06%
Interest Burden Percent		 105.04% 109.94% 102.44% 100.44% 94.58% 97.30% 98.73% 63.73% 97.87% 254.38% 2.89%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7.73% 0.00%
Return on Invested Capital (ROIC)		 0.00% -3,218.68% 0.00% -7,055.08% -1,067.91% -878.29% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -3,252.59% 0.00% -7,059.27% -1,066.45% -877.95% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 3,239.07% 0.00% 7,048.41% 1,052.02% 849.70% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% 20.39% 9.50% -6.67% -15.89% -28.59% -27.77% -21.44% -43.00% 14.65% 5.04%
Cash Return on Invested Capital (CROIC)		 0.00% -3,418.68% 0.00% -492.53% 0.00% -535.20% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% -4.18% -16.16% -11.34% -16.22% -29.08% -32.32% -32.29% -34.92% 1.99% -3.00%
Return on Assets (ROA)		 0.00% 4.54% 5.09% -4.88% -12.62% -20.79% -19.43% -15.93% -30.01% 8.76% 2.99%
Return on Common Equity (ROCE)		 0.00% 16.62% 8.30% -6.25% -15.07% -26.70% -25.78% -20.23% -40.97% 14.23% 4.96%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 12.51% 7.90% -4.97% -18.33% -36.00% -23.86% -16.93% -59.04% 13.84% 5.02%
Net Operating Profit after Tax (NOPAT)		 -13 -6.84 -33 -37 -65 -102 -138 -230 -285 17 -31
NOPAT Margin		 -14.64% -3.84% -15.13% -15.50% -30.29% -50.01% -60.39% -64.53% -66.93% 2.02% -4.85%
Net Nonoperating Expense Percent (NNEP)		 0.00% 33.91% 29.78% 4.19% -1.45% -0.34% 5.29% 7.80% -8.58% 10.91% 8.13%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -43.57% 2.06% -3.58%
Cost of Revenue to Revenue		 61.24% 58.84% 72.35% 72.89% 67.23% 78.16% 82.69% 72.51% 72.96% 45.88% 55.36%
SG&A Expenses to Revenue		 19.27% 16.74% 18.32% 17.94% 22.72% 25.84% 26.91% 35.70% 31.92% 15.89% 17.92%
R&D to Revenue		 34.25% 26.58% 30.95% 31.31% 53.32% 67.45% 76.66% 83.98% 90.73% 36.04% 33.66%
Operating Expenses to Revenue		 59.67% 46.64% 49.26% 49.25% 76.04% 93.28% 103.57% 119.68% 122.65% 51.93% 51.57%
Earnings before Interest and Taxes (EBIT)		 -19 -9.59 -46 -53 -92 -145 -192 -339 -419 23 -38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -19 -9.59 -46 -53 -92 -145 -192 -339 -419 23 -38
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 1.04 0.79 1.16 8.82 5.17 4.19 4.29 3.30
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 1.05 0.80 1.16 8.82 5.17 4.19 4.29 3.30
Price to Revenue (P/Rev)		 0.00 0.00 0.00 1.98 1.43 1.63 18.73 14.34 5.99 3.74 3.98
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 31.08 66.55
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.22% 1.50%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 2.36 0.00 2.96 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.12 0.00 0.34 16.48 11.50 4.45 2.73 2.68
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 99.89 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 99.89 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 135.05 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10.44 3,394.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 28.92 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.49 0.23 0.06 0.06 0.09 0.05 0.03 0.03 0.11 0.11
Long-Term Debt to Equity		 0.00 0.26 0.13 0.00 0.06 0.09 0.05 0.00 0.03 0.06 0.08
Financial Leverage		 0.00 -1.00 -1.04 -1.00 -0.99 -0.97 -1.01 -1.03 -1.04 -1.12 -1.12
Leverage Ratio		 0.00 2.24 1.87 1.36 1.26 1.38 1.43 1.35 1.43 1.67 1.69
Compound Leverage Factor		 0.00 2.47 1.91 1.37 1.19 1.34 1.41 0.86 1.40 4.26 0.05
Debt to Total Capital		 0.00% 32.77% 18.65% 5.82% 6.09% 7.89% 4.92% 2.52% 2.76% 9.64% 9.69%
Short-Term Debt to Total Capital		 0.00% 15.17% 7.96% 5.82% 0.00% 0.00% 0.00% 2.52% 0.00% 3.79% 2.73%
Long-Term Debt to Total Capital		 0.00% 17.60% 10.70% 0.00% 6.09% 7.89% 4.92% 0.00% 2.76% 5.86% 6.95%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 12.44% 7.89% 4.51% 5.30% 7.33% 6.38% 4.93% 4.05% 1.56% 1.40%
Common Equity to Total Capital		 0.00% 54.80% 73.46% 89.67% 88.61% 84.78% 88.70% 92.54% 93.19% 88.79% 88.92%
Debt to EBITDA		 0.00 -5.20 -1.01 -0.56 -0.29 -0.18 -0.14 -0.08 -0.04 3.46 -2.16
Net Debt to EBITDA		 0.00 10.62 4.66 8.87 4.50 1.99 2.85 3.13 1.64 -37.32 21.82
Long-Term Debt to EBITDA		 0.00 -2.79 -0.58 0.00 -0.29 -0.18 -0.14 0.00 -0.04 2.10 -1.55
Debt to NOPAT		 0.00 -7.29 -1.43 -0.80 -0.41 -0.26 -0.20 -0.12 -0.06 4.68 -2.71
Net Debt to NOPAT		 0.00 14.89 6.59 12.64 6.36 2.82 3.98 4.62 2.41 -50.45 27.33
Long-Term Debt to NOPAT		 0.00 -3.91 -0.82 0.00 -0.41 -0.26 -0.20 0.00 -0.06 2.84 -1.94
Altman Z-Score		 0.00 0.00 0.00 3.06 1.53 0.38 11.74 8.81 2.22 3.92 3.13
Noncontrolling Interest Sharing Ratio		 0.00% 18.50% 12.64% 6.24% 5.18% 6.64% 7.18% 5.61% 4.72% 2.85% 1.63%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 1.10 1.76 4.13 4.33 2.80 3.35 3.89 2.37 2.72 2.83
Quick Ratio		 0.00 0.98 1.58 3.91 4.03 2.52 3.05 3.51 2.06 2.56 2.65
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -7.26 -21 -61 -52 -126 -85 -237 -257 79 -78
Operating Cash Flow to CapEx		 224.16% -282.34% -221.15% -178.18% -516.14% -944.68% -780.80% -1,245.19% -732.60% 672.32% 2.77%
Free Cash Flow to Firm to Interest Expense		 0.00 -5.17 -12.82 -42.04 -51.69 -122.67 -108.24 -400.22 -394.70 104.31 -27.30
Operating Cash Flow to Interest Expense		 5.51 -6.68 -5.87 -6.15 -32.55 -78.56 -78.86 -344.97 -411.96 288.88 0.17
Operating Cash Flow Less CapEx to Interest Expense		 3.05 -9.05 -8.52 -9.60 -38.86 -86.87 -88.96 -372.68 -468.19 245.91 -6.07
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.78 0.76 0.51 0.38 0.41 0.38 0.34 0.36 0.73 0.49
Accounts Receivable Turnover		 0.00 3.73 4.60 4.97 4.52 3.67 3.94 5.42 4.67 6.86 4.08
Inventory Turnover		 0.00 10.97 13.97 14.29 11.95 11.23 10.48 9.30 6.73 7.19 6.93
Fixed Asset Turnover		 0.00 20.95 23.41 19.96 13.89 10.94 10.13 10.88 7.28 9.54 6.56
Accounts Payable Turnover		 0.00 1.86 3.21 4.87 5.01 6.36 6.74 7.10 5.54 7.16 8.85
Days Sales Outstanding (DSO)		 0.00 97.84 79.34 73.38 80.69 99.52 92.66 67.36 78.14 53.21 89.42
Days Inventory Outstanding (DIO)		 0.00 33.26 26.12 25.55 30.55 32.50 34.83 39.24 54.23 50.77 52.65
Days Payable Outstanding (DPO)		 0.00 196.69 113.65 74.98 72.83 57.41 54.15 51.44 65.87 51.00 41.25
Cash Conversion Cycle (CCC)		 0.00 -65.59 -8.19 23.95 38.41 74.60 73.33 55.16 66.49 52.98 100.83
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 0.43 -11 12 -0.28 24 -29 -22 -50 -112 -64
Invested Capital Turnover		 0.00 838.60 -39.52 455.10 35.26 17.56 -86.65 -14.07 -11.92 -10.36 -7.15
Increase / (Decrease) in Invested Capital		 0.00 0.43 -12 24 -13 24 -52 7.11 -28 -62 48
Enterprise Value (EV)		 0.00 0.00 0.00 29 -82 70 3,758 4,097 1,895 2,290 1,687
Market Capitalization		 0.00 0.00 0.00 479 307 334 4,271 5,106 2,556 3,132 2,511
Book Value per Share		 $0.00 $1.53 $3.09 $7.61 $5.85 $4.32 $0.69 $1.36 $0.71 $0.84 $0.87
Tangible Book Value per Share		 $0.00 $1.45 $3.03 $7.54 $5.80 $4.32 $0.69 $1.36 $0.71 $0.84 $0.87
Total Capital		 0.00 152 251 515 439 340 546 1,066 655 823 855
Total Debt		 0.00 50 47 30 27 27 27 27 18 79 83
Total Long-Term Debt		 0.00 27 27 0.00 27 27 27 0.00 18 48 59
Net Debt		 0.00 -102 -215 -473 -413 -289 -548 -1,061 -687 -855 -836
Capital Expenditures (CapEx)		 3.73 3.32 4.33 5.02 6.36 8.57 7.95 16 37 33 18
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -0.41 -11 -0.71 -16 -13 -63 -84 -145 -161 -123
Debt-free Net Working Capital (DFNWC)		 0.00 32 92 358 285 204 372 927 486 725 713
Net Working Capital (NWC)		 0.00 8.45 72 328 285 204 372 900 486 694 690
Net Nonoperating Expense (NNE)		 -8.70 -17 -47 -14 6.44 1.21 -22 -63 75 -84 -69
Net Nonoperating Obligations (NNO)		 0.00 -102 -215 -473 -413 -289 -548 -1,061 -687 -855 -836
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -0.23% -5.31% -0.30% -7.42% -6.47% -27.56% -23.69% -34.01% -19.26% -19.48%
Debt-free Net Working Capital to Revenue		 0.00% 17.69% 42.68% 148.25% 133.14% 99.53% 163.33% 260.39% 113.97% 86.51% 113.20%
Net Working Capital to Revenue		 0.00% 4.74% 33.44% 135.82% 133.14% 99.53% 163.33% 252.84% 113.97% 82.79% 109.49%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 ($0.43) ($1.13) ($0.16) ($0.18) ($0.25) ($0.43) $0.12 $0.04
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 59.72M 61.72M 66.43M 666.91M 727.72M 792.68M 847.14M 849.65M 855.35M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 ($0.43) ($1.13) ($0.16) ($0.18) ($0.25) ($0.43) $0.12 $0.04
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 59.97M 61.72M 66.43M 666.91M 727.72M 792.68M 847.14M 869.20M 872.83M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 ($0.16) ($0.18) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 60.71M 66.45M 66.66M 665.68M 697.93M 864.53M 864.78M 871.26M 871.60M
Normalized Net Operating Profit after Tax (NOPAT)		 -13 -6.84 -33 -37 -65 -102 -138 -230 -285 17 -31
Normalized NOPAT Margin		 -14.64% -3.84% -15.13% -15.50% -30.29% -50.01% -60.39% -64.53% -66.93% 2.02% -4.85%
Pre Tax Income Margin		 -22.85% -5.91% -21.92% -22.20% -40.47% -68.87% -83.23% -60.58% -96.25% 6.96% -0.18%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -12.53 -6.83 -28.34 -36.63 -90.81 -140.80 -244.20 -571.85 -643.20 30.20 -13.34
NOPAT to Interest Expense		 -8.43 -4.87 -20.04 -25.70 -64.27 -99.49 -174.93 -388.21 -437.71 22.34 -10.65
EBIT Less CapEx to Interest Expense		 -14.99 -9.20 -31.00 -40.08 -97.11 -149.11 -254.30 -599.55 -699.44 -12.77 -19.59
NOPAT Less CapEx to Interest Expense		 -10.89 -7.24 -22.69 -29.15 -70.58 -107.80 -185.03 -415.92 -493.94 -20.63 -16.90
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 -28.85% 5.66% 3.87% -6.94% -1.80% -1.24% -1.27% -5.92% -7.10% 8.97% 2.62%
Augmented Payout Ratio		 -28.85% 35.46% 96.68% -50.24% -10.48% -1.57% -19.48% -39.94% -20.47% 17.94% 97.10%

Quarterly Metrics and Ratios for HUTCHMED

No quarterly metrics and ratios for HUTCHMED are available.

Frequently Asked Questions About HUTCHMED's Financials

When does HUTCHMED's financial year end?

According to the most recent income statement we have on file, HUTCHMED's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has HUTCHMED's net income changed over the last 10 years?

HUTCHMED's net income appears to be on an upward trend, with a most recent value of $38.17 million in 2024, falling from -$4.09 million in 2014. The previous period was $101.09 million in 2023. Check out HUTCHMED's forecast to explore projected trends and price targets.

What is HUTCHMED's operating income?
HUTCHMED's total operating income in 2024 was -$43.71 million, based on the following breakdown:
  • Total Gross Profit: $281.32 million
  • Total Operating Expenses: $325.02 million
How has HUTCHMED revenue changed over the last 10 years?

Over the last 10 years, HUTCHMED's total revenue changed from $87.33 million in 2014 to $630.20 million in 2024, a change of 621.6%.

How much debt does HUTCHMED have?

HUTCHMED's total liabilities were at $502.34 million at the end of 2024, a 6.3% decrease from 2023, and a 294.5% increase since 2015.

How much cash does HUTCHMED have?

In the past 9 years, HUTCHMED's cash and equivalents has ranged from $31.94 million in 2015 to $377.54 million in 2021, and is currently $153.96 million as of their latest financial filing in 2024.

How has HUTCHMED's book value per share changed over the last 10 years?

Over the last 10 years, HUTCHMED's book value per share changed from 0.00 in 2014 to 0.87 in 2024, a change of 87.2%.


Related Companies

This page (NASDAQ:HCM) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners
Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Shocking AI play that’s beats Nvidia by a country mile
You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...
Timothy Sykes | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
Most traders are panicking. We’re cashing in
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Elon Musk is all in on these robots …
Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...
Weiss Ratings | Sponsored